GT Biopharma Stock (NASDAQ: GTBP) stock price, news, charts, stock research, profile.
You can purchase shares of GT Biopharma (NASDAQ:GTBP) through any online brokerage.
Other companies in GT Biopharma’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Vincerx Pharma (NASDAQ:VINC), Syros Pharmaceuticals (NASDAQ:SYRS), Alzamend Neuro (NASDAQ:ALZN) and Galecto (NASDAQ:GLTO).
GT Biopharma has a consensus price target of $6.00.
The stock price for GT Biopharma (NASDAQ: GTBP) is $3.06 last updated December 24, 2024 at 4:55 PM EST.
There are no upcoming dividends for GT Biopharma.
GT Biopharma’s Q4 earnings are confirmed for Tuesday, March 25, 2025.
There is no upcoming split for GT Biopharma.
GT Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.